Annual Working Capital
$95.93 M
-$47.21 M-32.98%
December 31, 2023
Summary
- As of February 22, 2025, PRQR annual working capital is $95.93 million, with the most recent change of -$47.21 million (-32.98%) on December 31, 2023.
- During the last 3 years, PRQR annual working capital has risen by +$10.18 million (+11.87%).
- PRQR annual working capital is now -48.30% below its all-time high of $185.56 million, reached on December 31, 2021.
Performance
PRQR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$58.94 M
-$10.18 M-14.73%
September 1, 2024
Summary
- As of February 22, 2025, PRQR quarterly working capital is $58.94 million, with the most recent change of -$10.18 million (-14.73%) on September 1, 2024.
- Over the past year, PRQR quarterly working capital has dropped by -$44.83 million (-43.20%).
- PRQR quarterly working capital is now -68.23% below its all-time high of $185.56 million, reached on December 31, 2021.
Performance
PRQR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PRQR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.0% | -43.2% |
| 3 y3 years | +11.9% | -22.3% |
| 5 y5 years | -16.3% | -22.3% |
PRQR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.3% | at low | -68.2% | at low |
| 5 y | 5-year | -48.3% | +11.9% | -68.2% | at low |
| alltime | all time | -48.3% | >+9999.0% | -68.2% | +6377.3% |
ProQR Therapeutics NV Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $58.94 M(-14.7%) |
| Jun 2024 | - | $69.12 M(-12.0%) |
| Mar 2024 | - | $78.55 M(-18.1%) |
| Dec 2023 | $95.93 M(-33.0%) | $95.93 M(-7.6%) |
| Sep 2023 | - | $103.77 M(-11.7%) |
| Jun 2023 | - | $117.56 M(-13.4%) |
| Mar 2023 | - | $135.71 M(-5.2%) |
| Dec 2022 | $143.14 M(-22.9%) | $143.14 M(+88.8%) |
| Sep 2022 | - | $75.81 M(-45.8%) |
| Jun 2022 | - | $139.89 M(-15.7%) |
| Mar 2022 | - | $166.03 M(-10.5%) |
| Dec 2021 | $185.56 M(+116.4%) | $185.56 M(+12.4%) |
| Sep 2021 | - | $165.14 M(+5.8%) |
| Jun 2021 | - | $156.14 M(+113.6%) |
| Mar 2021 | - | $73.12 M(-14.7%) |
| Dec 2020 | $85.75 M(-26.2%) | $85.75 M(-10.2%) |
| Sep 2020 | - | $95.50 M(+3.4%) |
| Jun 2020 | - | $92.36 M(-8.9%) |
| Mar 2020 | - | $101.35 M(-12.7%) |
| Dec 2019 | $116.13 M | $116.13 M(+58.6%) |
| Sep 2019 | - | $73.24 M(-16.4%) |
| Jun 2019 | - | $87.56 M(-11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $98.83 M(-13.8%) |
| Dec 2018 | $114.63 M(+127.1%) | $114.63 M(-7.5%) |
| Sep 2018 | - | $123.90 M(+304.2%) |
| Jun 2018 | - | $30.65 M(-24.4%) |
| Mar 2018 | - | $40.53 M(-19.7%) |
| Dec 2017 | $50.47 M(-13.7%) | $50.47 M(+17.6%) |
| Sep 2017 | - | $42.92 M(-5.8%) |
| Jun 2017 | - | $45.56 M(-11.8%) |
| Mar 2017 | - | $51.63 M(-11.7%) |
| Dec 2016 | $58.47 M(-42.1%) | $58.47 M(-15.0%) |
| Sep 2016 | - | $68.78 M(-14.6%) |
| Jun 2016 | - | $80.55 M(-13.8%) |
| Mar 2016 | - | $93.41 M(-7.4%) |
| Dec 2015 | $100.89 M(-25.2%) | $100.89 M(-8.3%) |
| Sep 2015 | - | $110.08 M(-5.3%) |
| Jun 2015 | - | $116.28 M(-3.2%) |
| Mar 2015 | - | $120.12 M(-10.9%) |
| Dec 2014 | $134.84 M(>+9900.0%) | $134.84 M(-6.1%) |
| Sep 2014 | - | $143.67 M(+190.2%) |
| Jun 2014 | - | $49.50 M(+5339.7%) |
| Dec 2013 | $910.00 K(+341.1%) | $910.00 K |
| Dec 2012 | $206.30 K | - |
FAQ
- What is ProQR Therapeutics NV annual working capital?
- What is the all time high annual working capital for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual working capital year-on-year change?
- What is ProQR Therapeutics NV quarterly working capital?
- What is the all time high quarterly working capital for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly working capital year-on-year change?
What is ProQR Therapeutics NV annual working capital?
The current annual working capital of PRQR is $95.93 M
What is the all time high annual working capital for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual working capital is $185.56 M
What is ProQR Therapeutics NV annual working capital year-on-year change?
Over the past year, PRQR annual working capital has changed by -$47.21 M (-32.98%)
What is ProQR Therapeutics NV quarterly working capital?
The current quarterly working capital of PRQR is $58.94 M
What is the all time high quarterly working capital for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly working capital is $185.56 M
What is ProQR Therapeutics NV quarterly working capital year-on-year change?
Over the past year, PRQR quarterly working capital has changed by -$44.83 M (-43.20%)